CYTH Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Stats
Dagens volum	28 089.00
Gjennomsnittsvolum	100 379
Markedsverdi	36.18M
EPS	$0 ( 2024-03-18 )
Neste inntjeningsdato	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.020
ATR14	$0.0120 (0.95%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Sieger Markus	Buy	14 004	Common Stock
2024-02-13	Ostronic Francis Patrick	Buy	8 703	Common Stock
2024-02-13	Toig Randall M.	Buy	7 516	Common Stock
2024-02-13	Strattan Ce Rick	Buy	6 963	Common Stock
2024-02-13	Wong Vivien	Buy	6 330	Common Stock

INSIDER POWER
50.71
Last 99 transactions
Buy: 16 269 213 \| Sell: 5 479 045

Volum Korrelasjon

Lang: 0.19 (neutral)

Kort: 0.15 (neutral)

Signal:(37.758) Neutral

Cyclo Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner
STRO	0.944
ASPU	0.94
LSXMK	0.922
LSXMA	0.922
PRTG	0.917
NAKD	0.917
BOCH	0.915
SIRI	0.911
ACRX	0.91
BFRI	0.91

10 Mest negative korrelasjoner
PAE	-0.928
RMRM	-0.927
APOP	-0.916
PESI	-0.907
EBSB	-0.905
INTA	-0.905
LMNR	-0.905
NCAC	-0.903
NVDA	-0.903
FTNT	-0.902

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Cyclo Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.33
( neutral )

-0.01
( neutral )

0.00
( neutral )

Cyclo Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$1.08M
Bruttogevinst:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2023
Omsetning:	$1.08M
Bruttogevinst:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2022
Omsetning:	$1.38M
Bruttogevinst:	$1.24M (89.90 %)
EPS:	$-1.810

FY	2021
Omsetning:	$1.59M
Bruttogevinst:	$1.43M (90.16 %)
EPS:	$-2.24

Financial Reports:

No articles found.

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.